The University of Colorado Cancer Center, together with other participating academic medical centers, recently opened a phase I human clinical trial of the drug OMP-54F28 in patients with advanced solid tumor cancers. OMP-54F28, ...
Oct 3, 2012
0
0
(Medical Xpress)—Each year, more and more pieces of the human genome puzzle fall into place, but large holes still remain. Researchers at the University of Wisconsin-Madison hope to fill in many more pieces with a new $1.1 ...
Oct 3, 2012
0
0
Kessler Foundation has released preliminary research findings from its clinical study of the wearable robotic exoskeletal device, Ekso (Ekso Bionics). Gail Forrest, PhD, assistant director of Human Performance and Engineering ...
Sep 5, 2012
0
0
Researchers at the University of Toronto and the Hospital for Sick Children (SickKids) are paving the way towards individualized medicine for patients with cystic fibrosis.
Aug 29, 2012
0
0
Kessler Foundation has begun testing the upgraded Ekso in individuals unable to walk due to spinal cord injury. Ekso, a wearable, battery-powered robotic exoskeletal device, has been undergoing clinical investigation at Kessler ...
Aug 14, 2012
0
0
A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs' Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can ...
Apr 9, 2012
0
2
The constant focus on customer needs that drives the design of everything from automobiles to personal computers has now been applied to a field traditionally immune to such concepts: the scientific study of disease.
Mar 22, 2012
0
2
(AP) -- Polish health authorities have ordered the withdrawal from the market of more than 230,000 kilograms (500,000 pounds) of pickles, bread and other food suspected of containing industrial salt, the latest development ...
Mar 9, 2012
0
0
Wii remotes are not all about fun and games. Scientists can use them to assess and diagnose children with an abnormal head position caused by eye diseases. As described in a recent Investigative Ophthalmology & Visual Science ...
Mar 8, 2012
0
0
The investigational drug ganetespib, a synthetic second-generation Hsp90 inhibitor, slowed the growth of cancer cells taken from non-small cell lung cancer tumors with a mutation in the KRAS gene. The drug was even more active ...
Jan 11, 2012
0
0
